HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dominique Barbolosi Selected Research

folfirinox

1/2021Population pharmacokinetic model of irinotecan and its four main metabolites in patients treated with FOLFIRI or FOLFIRINOX regimen.
1/2019Population pharmacokinetics of FOLFIRINOX: a review of studies and parameters.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dominique Barbolosi Research Topics

Disease

13Neoplasms (Cancer)
03/2022 - 02/2003
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2014
3Breast Neoplasms (Breast Cancer)
04/2017 - 09/2014
2Lung Neoplasms (Lung Cancer)
01/2022 - 09/2014
2Mesothelioma
01/2022 - 07/2017
2Neoplasm Metastasis (Metastasis)
03/2019 - 04/2017
1Prostatic Neoplasms (Prostate Cancer)
01/2023
1Brain Neoplasms (Brain Tumor)
03/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Neutropenia
03/2019
1Sarcoma (Soft Tissue Sarcoma)
03/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2019
1Paraganglioma (Paragangliomas)
01/2018
1Pheochromocytoma
01/2018
1Thyroid Neoplasms (Thyroid Cancer)
06/2017
1Inflammation (Inflammations)
01/2017
1Malignant Mesothelioma
04/2016
1Leukemia
09/2014
1Rhabdomyosarcoma
09/2014
1Neoplasm Micrometastasis
03/2009
1Drug-Related Side Effects and Adverse Reactions
02/2003

Drug/Important Bio-Agent (IBA)

4Vinorelbine (Navelbine)FDA LinkGeneric
01/2022 - 09/2014
2folfirinoxIBA
01/2021 - 01/2019
2Bevacizumab (Avastin)FDA Link
01/2018 - 04/2017
1Messenger RNA (mRNA)IBA
01/2023
1HSP27 Heat-Shock ProteinsIBA
01/2023
1Antisense OligonucleotidesIBA
01/2023
1Immune Checkpoint InhibitorsIBA
12/2021
1Monoclonal AntibodiesIBA
01/2021
17-ethyl-10-hydroxycamptothecin beta-glucuronideIBA
01/2021
1Irinotecan (Camptosar)FDA LinkGeneric
01/2021
1AlbuminsIBA
03/2019
1TrabectedinIBA
03/2019
1Hemoglobins (Hemoglobin)IBA
03/2019
1Cisplatin (Platino)FDA LinkGeneric
01/2018
1Pemetrexed (MTA)FDA Link
01/2018
1Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2018
1ThyroglobulinFDA Link
06/2017
1IodineIBA
06/2017
1Paclitaxel (Taxol)FDA LinkGeneric
04/2017
1GemcitabineFDA Link
01/2017
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2016
1Hormones (Hormone)IBA
04/2016
1Docetaxel (Taxotere)FDA Link
04/2016
1Epirubicin (Ellence)FDA LinkGeneric
04/2016
1Antineoplastic Agents (Antineoplastics)IBA
02/2003

Therapy/Procedure

6Drug Therapy (Chemotherapy)
01/2018 - 02/2003
5Therapeutics
01/2018 - 12/2015
3Immunotherapy
12/2021 - 12/2015
2Radiotherapy
03/2022 - 01/2016
1Castration
01/2023
1Drug Tapering
03/2019
1Precision Medicine
06/2017
1Aftercare (After-Treatment)
01/2017
1Biological Therapy
12/2015